Novocure Ltd
NASDAQ:NVCR

Watchlist Manager
Novocure Ltd Logo
Novocure Ltd
NASDAQ:NVCR
Watchlist
Price: 13.48 USD 0.3% Market Closed
Market Cap: 1.5B USD

Wall Street
Price Targets

NVCR Price Targets Summary
Novocure Ltd

Wall Street analysts forecast NVCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVCR is 25.28 USD with a low forecast of 13.64 USD and a high forecast of 44.1 USD.

Lowest
Price Target
13.64 USD
1% Upside
Average
Price Target
25.28 USD
88% Upside
Highest
Price Target
44.1 USD
227% Upside
Novocure Ltd Competitors:
Price Targets
6960
Fukuda Denshi Co Ltd
2% Downside
SHL
Siemens Healthineers AG
27% Upside
STE
STERIS plc
13% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
45% Upside
688271
Shanghai United Imaging Healthcare Co Ltd
36% Upside
ATRC
AtriCure Inc
32% Upside
SMLR
Semler Scientific Inc
301% Upside
DIA
DiaSorin SpA
32% Upside

Revenue
Forecast

Revenue Estimate
Novocure Ltd

For the last 10 years the compound annual growth rate for Novocure Ltd's revenue is 44%. The projected CAGR for the next 4 years is 12%.

44%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVCR's stock price target?
Price Target
25.28 USD

According to Wall Street analysts, the average 1-year price target for NVCR is 25.28 USD with a low forecast of 13.64 USD and a high forecast of 44.1 USD.

What is Novocure Ltd's Revenue forecast?
Projected CAGR
12%

For the last 10 years the compound annual growth rate for Novocure Ltd's revenue is 44%. The projected CAGR for the next 4 years is 12%.

Back to Top